BMS-587101

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBMS-587101
Drug Alias NameLFA-1 antagonistLymphocyte function-associated antigen-1 antagonist - Bristol-Myers SquibbBMS-587101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-L/beta-2 (LFA-1) antagonists
TargetsIntegrin alpha-L/beta-2 (LFA-1)
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb Srlcompany
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A